Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2013-06-30
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Aim 1: To assess the effect of an acute bout of IWT vs. an acute bout of CWT on glycemic control in type 2 diabetics and to assess mechanisms responsible for differences (if any). It is hypothesised that IWT will be more advantageous for improving glycemic control.
* Aim 2: To examine the effect of an acute bout of IWT vs. an acute bout of CWT on EPOC. It is hypothesised that IWT will produce an EPOC of larger magnitude than CWT.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Features Behind the Beneficial Effects of Interval-walking
NCT02257190
Interval-training and Appetite Regulation in Patients With Type 2 Diabetes
NCT02592616
Optimization of Interval-training in Patients With Type 2 Diabetes
NCT02601482
Exercise Training and Type 2 Diabetes
NCT01234155
Interval-training in Type 2 Diabetics
NCT02320526
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
No exercise (control experiment)
No interventions assigned to this group
Interval Walking
A one hour interval walking exercise bout
Interval Walking
Continuous walking
A one hour continuous walking exercise bout
Continuous walking
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Interval Walking
Continuous walking
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* insulin dependence
* Contraindication to physical activity (as judged by medical history and screening)
* Evidence of thyroid, liver, lung, kidney or heart disease
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Inge Holm
Administrator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristian Karstoft, MD
Role: PRINCIPAL_INVESTIGATOR
Centre of Inflammation and Metabolism (CIM), Rigshospitalet, Tagensvej 20, section M7641, DK-2100 Copenhagen, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre of Inflammation and Metabolism (CIM), Rigshospitalet, Tagensvej 20, section M7641
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Karstoft K, Christensen CS, Pedersen BK, Solomon TP. The acute effects of interval- Vs continuous-walking exercise on glycemic control in subjects with type 2 diabetes: a crossover, controlled study. J Clin Endocrinol Metab. 2014 Sep;99(9):3334-42. doi: 10.1210/jc.2014-1837. Epub 2014 Jun 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-3-2012-141
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.